Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00136825 · ClinicalTrials.gov registry record · Phase 1
Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1
A Phase 1 study of Cocaine-Related Disorders, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT00136825 is a Phase 1 study of Cocaine-Related Disorders that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 17 participants, below the 64-participant average among 15 other Cocaine-Related Disorders trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00136825, a Phase 1 study of Cocaine-Related Disorders, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
Recent findings have suggested that N-acetylcysteine (NAC) substantially reduces cocaine drug-seeking behavior in formerly cocaine dependent rats. The purpose of this study is to determine the safety, tolerability, and cue reactivity effects of NAC in cocaine dependent individuals and non-dependent healthy controls.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG N-Acetylcysteine
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2003-03 |
| Est. Completion | 2005-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00136825
The ClinicalTrials.gov registry entry for NCT00136825 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 64-participant average among 15 other Cocaine-Related Disorders trials with a reported enrollment target (73% lower). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cocaine-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00136825 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT00136825 about?
NCT00136825 is a clinical study titled "Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1". Recent findings have suggested that N-acetylcysteine (NAC) substantially reduces cocaine drug-seeking behavior in formerly cocaine dependent rats. The purpose of this study is to determine the safety, tolerability, and cue reactivity effects of NAC in cocaine dependent individuals and non-dependent ...
What is the current status of trial NCT00136825?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2003-03. Estimated completion is 2005-09.
What conditions does trial NCT00136825 study?
This clinical trial studies the following conditions: Cocaine-Related Disorders.
What interventions are being tested in trial NCT00136825?
The interventions under investigation include: Placebo (DRUG), N-Acetylcysteine (DRUG).
Who is sponsoring clinical trial NCT00136825?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00136825 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management
COMPLETED · Phase 1
-
Cocaethylene as a Treatment for Cocaine Dependence - 1
COMPLETED · Phase 1
-
Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid
COMPLETED · Phase 1
-
Cocaine-Methylphendidate Interaction Study - 4
COMPLETED · Phase 1
-
Prepulse Inhibition of Startle in Cocaine Dependence - 7
COMPLETED · Phase 1
-
Progesterone for the Treatment of Cocaine Dependence - 1
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.